RAP 0.00% 20.5¢ raptor resources limited

Ann: ResApp to Present at Wilsons Healthcare IT Conference, page-31

  1. 8,772 Posts.
    lightbulb Created with Sketch. 581
    So you feel it is likely to not make it to FDA approval even with 3 of the top US hospitals willing to trial it. Seems like having sold early maybe somehow you are hoping it does not succeed. Can you give a reason why there is no clear path to generating revenue? Either way I don't hold much so I am prepared to take the risk as I have most of my holdings in a steady as she goes company.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.